Recipharm Investments & Fund Profile

Overview

Contract development and manufacturing organization for pharmaceuticals.

Founded

1995

Deals · 12mo

0

Links

Website LinkedIn X (Twitter)

Stage focus

Series A

Geographic focus

Sweden

Switzerland

Sector focus

Biotechnology

Manufacturing

Medical

Pharmaceutical

Investment portfolio

5rounds

LedParticipated

NAME	DATE	SIZE
NewBiologix	May 2023Led	$50 MSeries A
Cinclus Pharma	Mar 2020Participated	$26 MOther Equity
LIDDS	Dec 2015Led	$0.63 MOther Equity
Xspray Pharma	Sep 2015Led	$2 MOther Equity
Isofol Medical	Aug 2014Led	$1 MOther Equity
NewBiologix	May 2023Led	$50 MSeries A
Cinclus Pharma	Mar 2020Participated	$26 MOther Equity
LIDDS	Dec 2015Led	$0.63 MOther Equity
Xspray Pharma	Sep 2015Led	$2 MOther Equity
Isofol Medical	Aug 2014Led	$1 MOther Equity

5 Items

5

Items

Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Recipharm: 5 funding rounds are recorded in the selected participation categories. All available history
Round type	Led deals	Participated deals
Series A	1	0
Other Equity	3	1

Monthly Deal Activity

Recipharm: 5 deals are recorded across 147 months. All available history
Month	Deals
Aug '14	1
Sep '14	0
Oct '14	0
Nov '14	0
Dec '14	0
Jan '15	0
Feb '15	0
Mar '15	0
Apr '15	0
May '15	0
Jun '15	0
Jul '15	0
Aug '15	0
Sep '15	1
Oct '15	0
Nov '15	0
Dec '15	1
Jan '16	0
Feb '16	0
Mar '16	0
Apr '16	0
May '16	0
Jun '16	0
Jul '16	0
Aug '16	0
Sep '16	0
Oct '16	0
Nov '16	0
Dec '16	0
Jan '17	0
Feb '17	0
Mar '17	0
Apr '17	0
May '17	0
Jun '17	0
Jul '17	0
Aug '17	0
Sep '17	0
Oct '17	0
Nov '17	0
Dec '17	0
Jan '18	0
Feb '18	0
Mar '18	0
Apr '18	0
May '18	0
Jun '18	0
Jul '18	0
Aug '18	0
Sep '18	0
Oct '18	0
Nov '18	0
Dec '18	0
Jan '19	0
Feb '19	0
Mar '19	0
Apr '19	0
May '19	0
Jun '19	0
Jul '19	0
Aug '19	0
Sep '19	0
Oct '19	0
Nov '19	0
Dec '19	0
Jan '20	0
Feb '20	0
Mar '20	1
Apr '20	0
May '20	0
Jun '20	0
Jul '20	0
Aug '20	0
Sep '20	0
Oct '20	0
Nov '20	0
Dec '20	0
Jan '21	0
Feb '21	0
Mar '21	0
Apr '21	0
May '21	0
Jun '21	0
Jul '21	0
Aug '21	0
Sep '21	0
Oct '21	0
Nov '21	0
Dec '21	0
Jan '22	0
Feb '22	0
Mar '22	0
Apr '22	0
May '22	0
Jun '22	0
Jul '22	0
Aug '22	0
Sep '22	0
Oct '22	0
Nov '22	0
Dec '22	0
Jan '23	0
Feb '23	0
Mar '23	0
Apr '23	0
May '23	1
Jun '23	0
Jul '23	0
Aug '23	0
Sep '23	0
Oct '23	0
Nov '23	0
Dec '23	0
Jan '24	0
Feb '24	0
Mar '24	0
Apr '24	0
May '24	0
Jun '24	0
Jul '24	0
Aug '24	0
Sep '24	0
Oct '24	0
Nov '24	0
Dec '24	0
Jan '25	0
Feb '25	0
Mar '25	0
Apr '25	0
May '25	0
Jun '25	0
Jul '25	0
Aug '25	0
Sep '25	0
Oct '25	0
Nov '25	0
Dec '25	0
Jan '26	0
Feb '26	0
Mar '26	0
Apr '26	0
May '26	0
Jun '26	0
Jul '26	0
Aug '26	0
Sep '26	0
Oct '26	0

Sector Breakdown

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Recipharm: Health & Life Sciences is the largest displayed sector by deal count (5 deals). All available history
Sector	Deals
Health & Life Sciences	5
Manufacturing	1

Deal Size Distribution

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Recipharm: 5 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)	Deals
<$5M	3
$5M-$10M	0
$10M-$25M	0
$25M-$50M	1
$50M-$100M	1
$100M-$250M	0
$250M-$500M	0
$500M-$1B	0
$1B+	0

Deals By Geography

Recipharm: Europe has the largest recorded deal count among the displayed regions (5 deals). All available history
Region	Deals
Europe	5

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.